“Assay”的搜索结果，显示 171-180 项，共有 6034 项

1. 肿瘤科（内科） - 临床试验- 妙佑医疗国际

   ... assay results. ROF2181. Rochester, Minn., Scottsdale/Phoenix, Ariz., Jacksonville, Fla. Currently, only a few international institutions use CIRT to treat ...

2. 脑肿瘤项目- 临床试验- 妙佑医疗国际

   CfDNA Assay Prospective Observational Validation For Early Cancer Detection And Minimal Residual Disease (CAMPERR). Rochester, Minn. The purpose of this ...

3. 肿瘤科（内科） - 临床试验- 妙佑医疗国际

   ... assay (IHC) and identified as appropriate for study participation if IHC staining is PS2+ in \>75% of cells (40% of all serous patients). Eligible patients ...

4. 血液科- 临床试验- 妙佑医疗国际

   CfDNA Assay Prospective Observational Validation For Early Cancer Detection And Minimal Residual Disease (CAMPERR). Rochester, Minn. The purpose of this ...

5. 脑肿瘤项目- 临床试验- 妙佑医疗国际

   CfDNA Assay Prospective Observational Validation For Early Cancer Detection And Minimal Residual Disease (CAMPERR). Rochester, Minn. The purpose of this ...

6. 肿瘤科（内科） - 临床试验- 妙佑医疗国际

   ... assay (IHC) and identified as appropriate for study participation if IHC staining is PS2+ in \>75% of cells (40% of all serous patients). Eligible patients ...

7. 肿瘤科（内科） - 临床试验- 妙佑医疗国际

   ... assay (IHC) and identified as appropriate for study participation if IHC staining is PS2+ in \>75% of cells (40% of all serous patients). Eligible patients ...

8. 血液科- 临床试验- 妙佑医疗国际

   The purpose of this study is to compare whether minimal residual disease (MRD) flow cytometric assay is not affected by different anticoagulants. Rituximab ...

9. 肿瘤科（内科） - 临床试验- 妙佑医疗国际

   ... assay results. Defining The Immunologic Profile Of Sentinel Lymph Nodes And Identifying The Mechanisms Responsible For Immunosuppression. Jacksonville, Fla ...

10. 肿瘤科（内科） - 临床试验- 妙佑医疗国际

    ... assay results. ROF2181. Rochester, Minn., Scottsdale/Phoenix, Ariz., Jacksonville, Fla. Currently, only a few international institutions use CIRT to treat ...